US 11026931
Methods for the administration of certain VMAT2 inhibitors
granted A61KA61K31/4375A61K31/4738
Quick answer
US patent 11026931 (Methods for the administration of certain VMAT2 inhibitors) held by Neurocrine Biosciences, Inc. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4375, A61K31/4738, A61K31/56, A61K9/0053